STRATA Skin Net Worth
STRATA Skin Net Worth Breakdown | SSKN |
STRATA Skin Net Worth Analysis
STRATA Skin's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including STRATA Skin's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of STRATA Skin's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform STRATA Skin's net worth analysis. One common approach is to calculate STRATA Skin's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares STRATA Skin's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing STRATA Skin's net worth. This approach calculates the present value of STRATA Skin's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of STRATA Skin's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate STRATA Skin's net worth. This involves comparing STRATA Skin's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into STRATA Skin's net worth relative to its peers.
Enterprise Value |
|
To determine if STRATA Skin is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding STRATA Skin's net worth research are outlined below:
| STRATA Skin Sciences had very high historical volatility over the last 90 days | |
| STRATA Skin Sciences has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 33.36 M. Net Loss for the year was (10.83 M) with profit before overhead, payroll, taxes, and interest of 19.85 M. | |
| STRATA Skin Sciences currently holds about 10.04 M in cash with (519 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.29. | |
| STRATA Skin Sciences has a poor financial position based on the latest SEC disclosures | |
| Roughly 60.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Strata Skin Sciences Inc Q3 2024 Earnings Call Highlights Navigating Challenges and ... |
STRATA Skin uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in STRATA Skin Sciences. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to STRATA Skin's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 29th of March 2024 Upcoming Quarterly Report | View | |
| 20th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 29th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know STRATA Skin's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as STRATA Skin is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading STRATA Skin Sciences backward and forwards among themselves. STRATA Skin's institutional investor refers to the entity that pools money to purchase STRATA Skin's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Jpmorgan Chase & Co | 2024-09-30 | 106 | Financial Perspectives Inc | 2024-09-30 | 101 | Royal Bank Of Canada | 2024-06-30 | 39.0 | Bank Of America Corp | 2024-06-30 | 17.0 | Hanson Mcclain Inc | 2024-09-30 | 5.0 | Pnc Financial Services Group Inc | 2024-09-30 | 2.0 | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 1.0 | Acadian Asset Management Llc | 2024-09-30 | 1.0 | Goldman Sachs Group Inc | 2024-06-30 | 0.0 | 22nw, Lp | 2024-09-30 | 537 K | Nantahala Capital Management, Llc | 2024-09-30 | 403.9 K |
Follow STRATA Skin's market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 12.85 M.Market Cap |
|
Project STRATA Skin's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.38) | (0.40) | |
| Return On Capital Employed | (0.29) | (0.30) | |
| Return On Assets | (0.26) | (0.27) | |
| Return On Equity | (0.85) | (0.81) |
When accessing STRATA Skin's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures STRATA Skin's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of STRATA Skin's profitability and make more informed investment decisions.
Evaluate STRATA Skin's management efficiency
STRATA Skin Sciences has return on total asset (ROA) of (0.0679) % which means that it has lost $0.0679 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6297) %, meaning that it created substantial loss on money invested by shareholders. STRATA Skin's management efficiency ratios could be used to measure how well STRATA Skin manages its routine affairs as well as how well it operates its assets and liabilities. As of the 3rd of December 2024, Return On Tangible Assets is likely to drop to -0.4. In addition to that, Return On Capital Employed is likely to drop to -0.3. At this time, STRATA Skin's Asset Turnover is very stable compared to the past year.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 3.63 | 3.45 | |
| Tangible Book Value Per Share | (0.33) | (0.31) | |
| Enterprise Value Over EBITDA | (8.30) | (8.72) | |
| Price Book Value Ratio | 1.51 | 1.59 | |
| Enterprise Value Multiple | (8.30) | (8.72) | |
| Price Fair Value | 1.51 | 1.59 | |
| Enterprise Value | 28.1 M | 23.3 M |
Understanding the management dynamics of STRATA Skin Sciences allows us to gauge its ability to sustain growth and profitability. This comprehensive analysis aids in determining the stock's value.
Enterprise Value Revenue 0.6813 | Revenue 32.7 M | Quarterly Revenue Growth 0.022 | Revenue Per Share 9.347 | Return On Equity (0.63) |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific STRATA Skin insiders, such as employees or executives, is commonly permitted as long as it does not rely on STRATA Skin's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases STRATA Skin insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
STRATA Skin Corporate Filings
| 22nd of November 2024 Other Reports | ViewVerify | |
10Q | 14th of November 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
8K | 13th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F3 | 29th of October 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
STRATA Skin Earnings per Share Projection vs Actual
STRATA Skin Corporate Management
| John Gillings | VP Finance | Profile | |
| Shmuel Gov | Chief Officer | Profile | |
| Robert Moccia | CEO Pres | Profile | |
| William MBA | Ex Chairman | Profile | |
| Michael Goodman | Head Sales | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in STRATA Skin Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of STRATA Skin. If investors know STRATA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about STRATA Skin listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.60) | Revenue Per Share 9.347 | Quarterly Revenue Growth 0.022 | Return On Assets (0.07) | Return On Equity (0.63) |
The market value of STRATA Skin Sciences is measured differently than its book value, which is the value of STRATA that is recorded on the company's balance sheet. Investors also form their own opinion of STRATA Skin's value that differs from its market value or its book value, called intrinsic value, which is STRATA Skin's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because STRATA Skin's market value can be influenced by many factors that don't directly affect STRATA Skin's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between STRATA Skin's value and its price as these two are different measures arrived at by different means. Investors typically determine if STRATA Skin is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, STRATA Skin's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.